124 related articles for article (PubMed ID: 23343082)
1. Selection and characterization of human anti-MAGE-A1 scFv and immunotoxin.
Lin H; Mao Y; Zhang DW; Li H; Qiu JR; Zhu J; Chen RJ
Anticancer Agents Med Chem; 2013 Oct; 13(8):1259-66. PubMed ID: 23343082
[TBL] [Abstract][Full Text] [Related]
2. Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody.
Saeed M; van Brakel M; Zalba S; Schooten E; Rens JA; Koning GA; Debets R; Ten Hagen TL
Int J Nanomedicine; 2016; 11():955-75. PubMed ID: 27022262
[TBL] [Abstract][Full Text] [Related]
3. Phage display-based on-slide selection of tumor-specific antibodies on formalin-fixed paraffin-embedded human tissue biopsies.
Ten Haaf A; Pscherer S; Fries K; Barth S; Gattenlöhner S; Tur MK
Immunol Lett; 2015 Aug; 166(2):65-78. PubMed ID: 26045318
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of a novel human scFv inhibiting EGFR vIII expressing cancers.
Rahbarnia L; Farajnia S; Babaei H; Majidi J; Dariushnejad H; Hosseini MK
Immunol Lett; 2016 Dec; 180():31-38. PubMed ID: 27984065
[TBL] [Abstract][Full Text] [Related]
5. Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin.
Dunn RD; Weston KM; Longhurst TJ; Lilley GG; Rivett DE; Hudson PJ; Raison RL
Immunotechnology; 1996 Sep; 2(3):229-40. PubMed ID: 9373315
[TBL] [Abstract][Full Text] [Related]
6. A novel Carcinoembryonic Antigen (CEA)-Targeted Trimeric Immunotoxin shows significantly enhanced Antitumor Activity in Human Colorectal Cancer Xenografts.
Lázaro-Gorines R; Ruiz-de-la-Herrán J; Navarro R; Sanz L; Álvarez-Vallina L; Martínez-Del-Pozo A; Gavilanes JG; Lacadena J
Sci Rep; 2019 Aug; 9(1):11680. PubMed ID: 31406218
[TBL] [Abstract][Full Text] [Related]
7. Generation of human and rabbit recombinant antibodies for the detection of Zearalenone by phage display antibody technology.
Sompunga P; Pruksametanan N; Rangnoi K; Choowongkomon K; Yamabhai M
Talanta; 2019 Aug; 201():397-405. PubMed ID: 31122440
[TBL] [Abstract][Full Text] [Related]
8. Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.
Chames P; Hufton SE; Coulie PG; Uchanska-Ziegler B; Hoogenboom HR
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7969-74. PubMed ID: 10884427
[TBL] [Abstract][Full Text] [Related]
9. Expression of a humanized single-chain variable fragment antibody targeting chronic myeloid leukemia cells in Escherichia coli and its characterization.
Zhu X; Wang D; Li S; Xiao Q; Tao K; Hu J; Cao W; Feng W
Int J Mol Med; 2012 May; 29(5):939-45. PubMed ID: 22322313
[TBL] [Abstract][Full Text] [Related]
10. Production of a recombinant anti-human CD4 single-chain variable-fragment antibody using phage display technology and its expression in Escherichia coli.
Babaei A; Zarkesh-Esfahani SH; Gharagozloo M
J Microbiol Biotechnol; 2011 May; 21(5):529-35. PubMed ID: 21617352
[TBL] [Abstract][Full Text] [Related]
11. Development of recombinant single-chain variable fragment against hepatitis A virus and its use in quantification of hepatitis A antigen.
Nimmagadda SV; Aavula SM; Biradhar N; Sula S; Lingala R; Chandran D; Villuppanoor SA
Biologicals; 2012 Jul; 40(4):299-308. PubMed ID: 22613789
[TBL] [Abstract][Full Text] [Related]
12. One-step expression and purification of single-chain variable antibody fragment using an improved hexahistidine tag phagemid vector.
Zhao Q; Chan YW; Lee SS; Cheung WT
Protein Expr Purif; 2009 Dec; 68(2):190-5. PubMed ID: 19683057
[TBL] [Abstract][Full Text] [Related]
13. Prokaryotic expression and refolding of EGFR extracellular domain and generation of phage display human scFv against EGFR.
Zhou Y; Zhang J; Jin H; Chen Z; Wu Q; Li W; Yue M; Luo C; Wang M
Biomed Pharmacother; 2013 Oct; 67(8):737-43. PubMed ID: 23639232
[TBL] [Abstract][Full Text] [Related]
14. Downstream characterization of anti-TNF-α single chain variable fragment antibodies.
Abdolalizadeh J; Nouri M; Zolbanin JM; Baradaran B; Barzegari A; Omidi Y
Hum Antibodies; 2012; 21(1-2):41-8. PubMed ID: 22885959
[TBL] [Abstract][Full Text] [Related]
15. Granzyme M as a novel effector molecule for human cytolytic fusion proteins: CD64-specific cytotoxicity of Gm-H22(scFv) against leukemic cells.
Schiffer S; Letzian S; Jost E; Mladenov R; Hristodorov D; Huhn M; Fischer R; Barth S; Thepen T
Cancer Lett; 2013 Dec; 341(2):178-85. PubMed ID: 23973499
[TBL] [Abstract][Full Text] [Related]
16. Selection of scFv Antibody Fragments Binding to Human Blood versus Lymphatic Endothelial Surface Antigens by Direct Cell Phage Display.
Keller T; Kalt R; Raab I; Schachner H; Mayrhofer C; Kerjaschki D; Hantusch B
PLoS One; 2015; 10(5):e0127169. PubMed ID: 25993332
[TBL] [Abstract][Full Text] [Related]
17. [Isolation and identification of single chain Fv antibodies against breast cancer from a human phage display library].
Wang J; Wang H; Wang C; Yuan Y; Cui Y; Ye J; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):837-40. PubMed ID: 22863591
[TBL] [Abstract][Full Text] [Related]
18. An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.
Klimka A; Barth S; Matthey B; Roovers RC; Lemke H; Hansen H; Arends JW; Diehl V; Hoogenboom HR; Engert A
Br J Cancer; 1999 Jun; 80(8):1214-22. PubMed ID: 10376974
[TBL] [Abstract][Full Text] [Related]
19. Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas.
Kuan CT; Wakiya K; Keir ST; Li J; Herndon JE; Pastan I; Bigner DD
Int J Cancer; 2011 Jul; 129(1):111-21. PubMed ID: 20824708
[TBL] [Abstract][Full Text] [Related]
20. Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties.
Pirie CM; Hackel BJ; Rosenblum MG; Wittrup KD
J Biol Chem; 2011 Feb; 286(6):4165-72. PubMed ID: 21138845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
